Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Rituximab With Corticosteroids Versus Standard Oral Corticosteroids Plus Azathioprine in Participants With Moderate-to-Severe Pemphigus Vulgaris: A Quasi-Experimental Study

NCT07769333 is registered in ClinicalTrials.gov with Khyber Teaching Hospital as lead sponsor.

NCT NCT07769333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07769333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Rituximab With Corticosteroids Versus Standard Oral Corticosteroids Plus Azathioprine in Participants With Moderate-to-Severe Pemphigus Vulgaris: A Quasi-Experimental Study
Lead sponsor
Khyber Teaching Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 2, 2026
Completion date
November 6, 2027
Enrollment
92 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus vulgaris, rituximab (rtx)